Premium
Recombinant granulocyte colony‐stimulating factor in the management of toxic epidermal necrolysis
Author(s) -
GOULDEN V.,
GOODFIELD M.J.D.
Publication year - 1996
Publication title -
british journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.304
H-Index - 179
eISSN - 1365-2133
pISSN - 0007-0963
DOI - 10.1111/j.1365-2133.1996.tb01167.x
Subject(s) - toxic epidermal necrolysis , granulocyte colony stimulating factor , recombinant dna , medicine , granulocyte , immunology , dermatology , chemistry , chemotherapy , biochemistry , gene
Summary We report a 7‐year‐old girl with extensive toxic epidermal necrolysis (TEN) and neutropenia who was successfully treated using recombinant granulocyte colony‐stimulating factor. Our patient had extensive epidermal loss and neutropenia, both indicators of a poor prognosis, but none the less made a rapid and complete recovery.